臨床研究の実績

  • TEL03-3353-1211
  • FAX03-3353-4707

〒160-8582 東京都新宿区信濃町35 慶應義塾大学MAP

お問い合わせ

MENU

臨床研究の実績

  • 1. Iwama N, Tsuruta M, Hasegawa H, Okabayashi K, Ishida T, Kitagawa Y. Relationship between anastomotic leakage and CT value of the mesorectum in laparoscopic anterior resection for rectal cancer. Jpn J Clin Oncol 2019.
  • 2. Uchino M, Ikeuchi H, Hata K, et al. Changes in the rate of and trends in colectomy for ulcerative colitis during the era of biologics and calcineurin inhibitors based on a Japanese nationwide cohort study. Surg Today. 2019;49(12):1066–1073.
  • 3. Matsui S, Okabayashi K, Tsuruta M, et al. Interleukin-13 and its signaling pathway is associated with obesity-related colorectal tumorigenesis. Cancer Sci. 2019;110(7):2156–2165.
  • 4. Takeuchi M, Obara H, Kawakubo H, et al. Comparison of olanexidine versus povidone-iodine for preventing surgical site infection in gastrointestinal surgery: study protocol for a multicentre, single-blind, randomised controlled clinical trial. BMJ Open. 2019;9(5):e028269.
  • 5. Takeuchi M, Kawakubo H, Mayanagi S, et al. Perioperative risk calculator for distal gastrectomy predicts overall survival in patients with gastric cancer. Gastric Cancer. 2019;22(3):624–631.
  • 6. Hasegawa H, Okabayashi K, Tsuruta M, Ishida T, Asahara F, Coleman MG. Evolution of surgery for rectal cancer: Transanal total mesorectal excision~new standard or fad?~. J Anus Rectum Colon. 2018;2(4):115–121.
  • 7. Suzumura H, Tsuruta M, Hasegawa H, Okabayashi K, Ishida T, Asada Y, Makino A, Okuda S, Kitagawa Y. The impact of the mesorectal apparent diffusion coefficient value on surgical difficulty in laparoscopic anterior resection for rectal cancer. Surg Today. 2019;49(3):239–244.
  • 8. Seishima R, Leung C, Yada S, et al. Neonatal Wnt-dependent Lgr5 positive stem cells are essential for uterine gland development. Nat Commun. 2019;10(1):5378.
  • 9. Shigeta K, Datta M, Hato T, et al. Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma. Hepatology. 2019;10.1002/hep.30889.
  • 10. Seishima R, Barker N. A contemporary snapshot of intestinal stem cells and their regulation. Differentiation. 2019;108:3–7.

和文論文

  • 1.松岡信成, 石田隆, 岡林剛史, 鶴田雅士, 横江隆道, 前田祐助, 蛭川和也, 長谷川博俊, 北川雄光.尿路変向を伴う泌尿器科術後に尿管が原因となって内ヘルニアを来した1例.日本消化器外科学会雑誌52巻10号 Page605-610(2019.10)
  • 1. Shimada T, Tsuruta M, Hasegawa H, Okabayashi K, Ishida T, Asada Y, Suzumura H, Kitagawa Y. Pelvic inlet shape measured by three-dimensional pelvimetry is a predictor of the operative time in the anterior resection of rectal cancer. Surg Today. 2018;48(1):51–57.
  • 2. Takesue Y, Kusachi S, Mikamo H, et al. Corrigendum to 'Antimicrobial susceptibility of pathogens isolated from surgical site infections in Japan: Comparison of data from nationwide surveillance studies conducted in 2010 and 2014-2015' [J Infect Chemother 23 (2017) 339-348]. J Infect Chemother. 2018;24(2):156–157.
  • 3. Shimada T, Tsuruta M, Hasegawa H, Okabayashi K, Shigeta K, Ishida T, Asada Y, Suzumura H, Koishikawa K, Akimoto S, Kitagawa Y. Heat shock protein 27 knockdown using nucleotide based therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells. Oncol Rep. 2018 Mar;39(3):1119-1124.
  • 4. Suzuki Y, Okabayashi K, Hasegawa H, Tsuruta M, Shigeta K, Kondo T, Kitagawa Y. Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer. Ann Surg. 2018;267(3):527–531.
  • 5. Tanoue T, Morita S, Plichta DR, Skelly AN, Suda W, Sugiura Y, Narushima S, Vlamakis H, Motoo I, Sugita K, Shiota A, Takeshita K, Yasuma-Mitobe K, Riethmacher D, Kaisho T, Norman JM, Mucida D, Suematsu M, Yaguchi T, Bucci V, Inoue T, Kawakami Y, Olle B, Roberts B, Hattori M, Xavier RJ, Atarashi K, Honda K. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature. 2019 Jan;565(7741):600-605.
  • 6. Takesue Y, Kusachi S, Mikamo H, et al. Corrigendum to "Antimicrobial susceptibility of common pathogens isolated from postoperative intra-abdominal infections in Japan" [J Infect Chemother 24 (2018) 330-340]. J Infect Chemother. 2018;24(7):592–595.
  • 7. Tsuruta M, Hasegawa H, Okabayashi K, et al. Needlescopic versus conventional laparoscopic surgery for colorectal cancer ~a comparative study~. J Anus Rectum Colon. 2018;1(2):45–49.
  • 8. Saito Y, Onishi N, Takami H, et al. Development of a functional thyroid model based on an organoid culture system. Biochem Biophys Res Commun. 2018;497(2):783–789.

和文論文

  • 1. 田島佑樹, 石田隆, 長谷川博俊, 岡林剛史, 鶴田雅士, 鈴木佳透, 北川雄光.術前診断しえた左傍十二指腸ヘルニアに対し、完全腹腔鏡下に修復した2例.日本腹部救急医学会雑誌 38巻5号 Page883-887(2018.07)
  • 2. 島田岳洋, 岡林剛史, 長谷川博俊, 鶴田雅士, 蔵本純子, 北川雄光.S状結腸内分泌細胞癌に対し腹腔鏡手術を施行した1例.日本外科系連合学会誌 43巻2号 Page216-221(2018.04)
  • 1. Kondo T, Tsuruta M, Hasegawa H, Okabayashi K, Shigeta K, Hayashida T, Kitagawa Y. The use of laparoscopic rectopexy to manage rectal prolapse with Pseudo-Meigs' syndrome in a 64-year-old female: a case report. Clin Case Rep. 2017 Mar 29;5(5):642-644.
  • 2. Yahagi M, Tsuruta M, Hasegawa H, Okabayashi K, Kitagawa Y. Non-alcoholic fatty liver disease fibrosis score predicts hematological toxicity of chemotherapy including irinotecan for colorectal cancer. Mol Clin Oncol. 2017 Apr;6(4):529-533.
  • 3. Ishida T, Ishii Y, Tsuruta M, Okabayashi K, Akimoto S, Koishikawa K, Hasegawa H, Kitagawa Y. Cetuximab promotes SN38 sensitivity via suppression of heat shock protein 27 in colorectal cancer cells with wild-type RAS. Oncol Rep. 2017 Aug;38(2):926-932.
  • 4. Tajima Y, Tsuruta M, Yahagi M, Hasegawa H, Okabayashi K, Shigeta K, Ishida T, Kitagawa Y. Is preoperative spirometry a predictive marker for postoperative complications after colorectal cancer surgery? Jpn J Clin Oncol. 2017 Sep 1;47(9):815-819.
  • 5. Tai-Nagara I, Yoshikawa Y, Numata N, et al. Placental labyrinth formation in mice requires endothelial FLRT2/UNC5B signaling. Development. 2017;144(13):2392–2401.
  • 6. Matsui S, Nitori N, Kato A, et al. Corrigendum to "Laparoscopic totally extra-peritoneal hernia repair for bilateral Spigelian hernias and coincident inguinal hernia: A case report" Int J Surg Case Rep. 2017;34:65.

和文論文

  • 1.高橋秀奈, 岡林剛史, 長谷川博俊, 鶴田雅士, 田島佑樹, 北川雄光.腹腔鏡補助下結腸右半切除術を施行した腸回転異常症を伴う上行結腸癌の1例.手術 71巻11号 Page1571-1574(2017.10)
  • 2.鈴村博史, 鶴田雅士, 長谷川博俊, 岡林剛史, 亀山香織, 北川雄光.複数箇所の腸管切除を要した腸管アメーバ症の1例.手術 71巻7号 Page1111-1114(2017.06)
  • 1. Matsui S, Nitori N, Kato A, Ikeda Y, Kiatagwa Y, Hasegawa H, Okabayashi K, Tsuruta M, Kitajima M. Laparoscopic totally extra-peritoneal hernia repair for bilateral Spigelian hernias and coincident inguinal hernia: A case report. Int J Surg Case Rep. 2016;28:169-172.
  • 2. Shimoda M, Horiuchi K, Sasaki A, Tsukamoto T, Okabayashi K, Hasegawa H, Kitagawa Y, Okada Y. Epithelial Cell-Derived a Disintegrin and Metalloproteinase-17 Confers Resistance to Colonic Inflammation Through EGFR Activation. EBioMedicine. 2016 Feb 9;5:114-24.
  • 3. Shigeta K, Okabayashi K, Baba H, Hasegawa H, Tsuruta M, Yamafuji K, Kubochi K, Kitagawa Y. A meta-analysis of the use of a transanal drainage tube to prevent anastomotic leakage after anterior resection by double-stapling technique for rectal cancer. Surg Endosc. 2016 Feb;30(2):543-550.
  • 4. Yamada T, Okabayashi K, Hasegawa H, Tsuruta M, Abe Y, Ishida T, Matsui S, Kitagawa Y. Age, Preoperative Subcutaneous Fat Area, and Open Laparotomy are Risk Factors for Incisional Hernia following Colorectal Cancer Surgery. Ann Surg Oncol. 2016 Feb;23 Suppl 2:S236-41.
  • 5. Yahagi M, Okabayashi K, Hasegawa H, Tsuruta M, Kitagawa Y. The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis. J Gastrointest Surg. 2016 Mar;20(3):648-55.
  • 6. Shigeta K, Baba H, Yamafuji K, Asami A, Takeshima K, Nagasaki K, Okamoto N, Murata T, Arai S, Kubochi K, Kitagawa Y. Effects of laparoscopic surgery on the patterns of death in elderly colorectal cancer patients: competing risk analysis compared with open surgery. Surg Today. 2016 Apr;46(4):422-9.
  • 7. Shigeta K, Ishii Y, Hasegawa H, Okabayashi K, Kitagawa Y. Clinical Usefulness of 5-FU Metabolic Enzymes as Predictive Markers of Response to Chemotherapy in Colorectal Cancer. World J Surg. 2016 Apr;40(4):1019-20.
  • 8. Matsuda M, Tsuruta M, Hasegawa H, Okabayashi K, Kondo T, Shimada T, Yahagi M, Yoshikawa Y, Kitagawa Y. Transanal drainage tube placement to prevent anastomotic leakage following colorectal cancer surgery with double stapling reconstruction. Surg Today. 2016 May;46(5):613-20.
  • 9. Yoshikawa Y, Yamada T, Tai-Nagara I, Okabe K, Kitagawa Y, Ema M, Kubota Y. Developmental regression of hyaloid vasculature is triggered by neurons. J Exp Med. 2016 Jun 27;213(7):1175-83.
  • 10. Kondo T, Okabayashi K, Hasegawa H, Tsuruta M, Shigeta K, Kitagawa Y. The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer. Br J Cancer. 2016 Jun 28;115(1):34-9.
  • 11. Shigeta K, Hasegawa H, Okabayashi K, Tsuruta M, Ishii Y, Endo T, Ochiai H, Kondo T, Kitagawa Y. Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancer. Int J Cancer. 2016 Aug 15;139(4):946-54.
  • 12. Shigeta K, Okabayashi K, Hasegawa H, Tsuruta M, Seishima R, Kitagawa Y. Meta-analysis of laparoscopic surgery for recurrent Crohn's disease. Surg Today. 2016 Aug;46(8):970-8.
  • 13. Seishima R, Okabayashi K, Nagano O, Hasegawa H, Tsuruta M, Shimoda M, Kameyama K, Saya H, Kitagawa Y. Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9(+) cancer stem cells in ulcerative colitis-related cancer. Clin Res Hepatol Gastroenterol. 2016 Sep;40(4):487-93.
  • 14. Suzuki Y, Okabayashi K, Hasegawa H, Tsuruta M, Shigeta K, Murakami K, Kitagawa Y. Metabolic Tumor Volume and Total Lesion Glycolysis in PET/CT Correlate With the Pathological Findings of Colorectal Cancer and Allow Its Accurate Staging.  Clin Nucl Med. 2016 Oct;41(10):761-5.
  • 15. Seishima R, Okabayashi K, Nagano O, et al. Sulfasalazine, a therapeutic agent for ulcerative colitis, inhibits the growth of CD44v9(+) cancer stem cells in ulcerative colitis-related cancer. Clin Res Hepatol Gastroenterol. 2016;40(4):487–493.

和文論文

  • 1.松井信平, 岡林剛史, 長谷川博俊, 鶴田雅士, 清島亮, 高橋秀奈, 山田暢, 松田睦史, 下田将之, 北川雄光.クローン病による回腸-十二指腸瘻で低栄養を来し,手術により改善を得た1例.日本消化器外科学会雑誌 49巻11号 Page1157-1163(2016.11)
  • 2.吉川祐輔, 鶴田雅士, 長谷川博俊, 岡林剛史, 近藤崇之, 島田岳洋, 松田睦史, 矢作雅史, 北川雄光.逸脱ステントを術中内視鏡下に回収した腹腔鏡下左半結腸切除の1例.日本消化器外科学会雑誌 49巻4号 Page334-341(2016.04)
  • 3.松田睦史, 岡林剛史, 中川健, 長谷川博俊, 鶴田雅士, 北川雄光.直腸癌と前立腺癌の重複癌に対し一期的腹腔鏡下手術を施行した1例.日本内視鏡外科学会雑誌 21巻3号 Page275-281(2016.05)
  • Shigeta K, Okabayashi K, Baba H, Hasegawa H, Tsuruta M, Yamafuji K, Kubochi K, Kitagawa Y. A meta-analysis of the use of a transanal drainage tube to prevent anastomotic leakage after anterior resection by double-stapling technique for rectal cancer. Surg Endosc. Online publish, 2015
  • Katsuno H, Maeda K, Kaiho T, Kunieda K, Funahashi K, Sakamoto J, Kono T, Hasegawa H, Furukawa Y, Imazu Y, Morita S, Watanabe M. Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902). Jpn J Clin Oncol. May 12. 2015
  • Seishima R, Uraoka T, Hasegawa H, Okabayashi K, Tsuruta M, Hayashi Y, Kitagawa Y. Colon cancer arising from a sessile serrated adenoma/polyp detected on positron emission tomography/computed tomography. Gastrointest Endosc, Online publish, 2015
  • Takahashi H, Okabayashi K, Tsuruta M, Hasegawa H, Yahagi M, Kitagawa Y. Self-Expanding Metallic Stents Versus Surgical Intervention as Palliative Therapy for Obstructive Colorectal Cancer: A Meta-analysis. World J Surg, Online publish, 2015
  • Seishima R, Wada T, Tsuchihashi K, Okazaki S, Yoshikawa M, Oshima H, Oshima M, Sato T, Hasegawa H, Kitagawa Y, Goldenring JR, Saya H, Nagano O. Ink4a/Arf-Dependent Loss of Parietal Cells Induced by Oxidative Stress Promotes CD44-Dependent Gastric Tumorigenesis. Cancer Prev Res (Phila). Jun;8(6):492-501. 2015
  • Yamada T, Okabayashi K, Hasegawa H, Tsuruta M, Abe Y, Ishida T, Matsui S, Kitagawa Y. Age, Preoperative Subcutaneous Fat Area, and Open Laparotomy are Risk Factors for Incisional Hernia following Colorectal Cancer Surgery. Ann Surg Oncol. Online publish, 2015
  • Matsui S, Uraoka T, Hasegawa H, Kitagawa Y. A case of asymptomatic incidental live anisakid worm infestation on a large rectal polyp. BMJ Case Rep. doi:10.1136/bcr-2014-208708, 2015
  • Seishima R, Okabayashi K, Hasegawa H, Tsuruta M, Hoshino H, Yamada T, Kitagawa Y. Computed tomography attenuation values of ascites are helpful to predict perforation site. World J Gastroenterol. Feb 21(5): 1573-9. 2015
  • Seishima R, Okabayashi K, Hasegawa H, Tsuruta M, Shigeta K, Matsui S, Yamada T, Kitagawa Y. Is laparoscopic colorectal surgery beneficial for elderly patients? A systematic review and meta-analysis. J Gastrointest Surg. Apr 19(4):756-65. 2015
  • Katsuno H, Maeda K, Kaiho T, Kunieda K, Funahashi K, Sakamoto J, Kono T, Hasegawa H, Furukawa Y, Imazu Y, Morita S, Watanabe M. Clinical efficacy of Daikenchuto for gastrointestinal dysfunction following colon surgery: a randomized, double-blind, multicenter, placebo-controlled study (JFMC39-0902). Jpn J Clin Oncol. May 12. 2015
  • Kishida N, Hibi T, Itano O, Okabayashi K, Shinoda M, Kitago M, Abe Y, Yagi H, Kitagawa Y. Validation of Hepatectomy for Elderly Patients with Hepatocellular Carcinoma. Ann Surg Oncol. Jan 13. 2015
  • Ei S, Hibi T, Tanabe M, Itano O, Shinoda M, Kitago M, Abe Y, Yagi H, Okabayashi K, Sugiyama D, Wakabayashi G, Kitagawa Y. Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolbox. Ann Surg Oncol. Apr;22(4):1294-300. 2015
  • Matsunaga A, Ishii Y, Tsuruta M, Okabayashi K, Hasegawa H, Kitagawa Y. Inhibition of heat shock protein 27 phosphorylation promotes sensitivity to 5-fluorouracil in colorectal cancer cells. Oncol Lett. Dec;8(6):2496-2500. 2014
  • Shigeta K, Ishii Y, Hasegawa H, Okabayashi K, Kitagawa Y. Evaluation of 5-fluorouracil metabolic enzymes as predictors of response to adjuvant chemotherapy outcomes in patients with stage II/III colorectal cancer: a decision-curve analysis. World J Surg. Dec;38(12):3248-56. 2014
  • Hoshino Y, Hayashida T, Hirata A, Takahashi H, Chiba N, Ohmura M, Wakui M, Jinno H, Hasegawa H, Maheswaran S, Suematsu M, Kitagawa Y. Bevacizumab terminates homeobox B9-induced tumor proliferation by silencing microenvironmental communication. Mol Cancer. May 5;13:102. 2014
  • Seishima R, Okabayashi K, Hasegawa H, Sugiyama D, Ishii Y, Tsuruta M, Takebayashi T, Kitagawa Y. Obesity was associated with a decreased postoperative recurrence of rectal cancer in a Japanese population. Surg Today. Dec;44(12):2324-31. 2014
  • Nagayama A, Hayashida T, Jinno H, Takahashi M, Seki T, Matsumoto A, Murata T, Ashrafian H, Athanasiou T, Okabayashi K, Kitagawa Y. Comparative effectiveness of neoadjuvant therapy for HER2-positive breast cancer: a network meta-analysis. J Natl Cancer Inst. Sep 15;106(9). 2014
  • Kikuchi H, Yagi H, Hasegawa H, Ishii Y, Okabayashi K, Tsuruta M, Hoshino G, Takayanagi A, Kitagawa Y. Therapeutic potential of transgenic mesenchymal stem cells engineered to mediate anti-high mobility group box 1 activity: targeting of colon cancer. J Surg Res. Jul;190(1):134-43. 2014
  • Seo Y, Ishii Y, Ochiai H, Fukuda K, Akimoto S, Hayashida T, Okabayashi K, Tsuruta M, Hasegawa H, Kitagawa Y. Cetuximab-mediated ADCC activity is correlated with the cell surface expression level of EGFR but not with the KRAS/BRAF mutational status in colorectal cancer. Oncol Rep. May;31(5):2115-22. 2014
  • Hasegawa H, Okabayashi K, Watanabe M, Ashrafian H, Harling L, Ishii Y, Sugiyama D, Seishima R, Darzi A, Athanasiou T, Kitagawa Y. What is the effect of laparoscopic colectomy on pattern of colon cancer recurrence? A propensity score and competing risk analysis compared with open colectomy. Ann Surg Oncol. Aug;21(8):2627-35. 2014
  • Hibi T, Nishida S, Sageshima J, Levi DM, Ruiz P, Roth D, Martin P, Okabayashi K, Burke GW, Ciancio G, Tzakis AG. Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C. Transpl Int. Jun;27(6):606-16. 2014
  • Shigeta K, Okabayashi K, Hasegawa H, Ishii Y, Ochiai H, Tsuruta M, Mukai M, Kameyama K, Uraoka T, Yahagi N, Kitagawa Y. Long-term outcome of patients with locally resected high- and low-risk rectal carcinoid tumors. J Gastrointest Surg. Apr;18(4):768-73. 2014
  • Moritani K, Hasegawa H, Okabayashi K, Ishii Y, Endo T, Kitagawa Y. Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution. Surg Today. Sep;44(9):1685-91. 2014
  • Okabayashi K, Ashrafian H, Zacharakis E, Hasegawa H, Kitagawa Y, Athanasiou T, Darzi A. Adhesions after abdominal surgery: a systematic review of the incidence, distribution and severity. Surg Today. Mar;44(3):405-20. 2014
  • Ishii Y, Hasegawa H, Endo T, Ochiai H, Okabayashi K, Kitagawa Y. Reduced-port laparoscopic surgery for rectal cancer: feasibility based on our early experience. Asian J Endosc Surg. Aug;6(3):249-52. 2013
  • Shigeta K, Hayashida T, Hoshino Y, Okabayashi K, Endo T, Ishii Y, Hasegawa H, Kitagawa Y. Expression of Epidermal Growth Factor Receptor Detected by Cetuximab Indicates Its Efficacy to Inhibit In Vitro and In Vivo Proliferation of Colorectal Cancer Cells. PLoS One. Jun 18;8(6):e66302. 2013
  • Iida S, Imai K, Matsuda S, Itano O, Hatakeyama M, Sakamoto S, Kokuryo D, Okabayashi K, Endo T, Ishii Y, Hasegawa H, Aoki I, Handa H, Kitagawa Y. In vivo identification of sentinel lymph nodes using MRI and size-controlled and monodispersed magnetite nanoparticles. J Magn Reson Imaging. Dec;38(6):1346-55. 2013
  • Garas G, Okabayashi K, Ashrafian H, Shetty K, Palazzo F, Tolley N, Darzi A, Athanasiou T, Zacharakis E. Which hemostatic device in thyroid surgery A network meta-analysis of surgical technologies. Thyroid. Sep;23(9):1138-50. 2013
  • Athanasiou T, Ashrafian H, Mukherjee D, Harling L, Okabayashi K. Are arterial grafts superior to vein grafts for revascularisation of the right coronary system A systematic review. Heart. Jun;99(12):835-42. 2013
  • Seishima R, Ishii Y, Hasegawa H, Endo T, Ochiai H, Okabayashi K, Mukai M, Kitagawa Y. Large liposarcoma developing in the ischiorectal fossa: Report of a rare case. Int J Surg Case Rep. 4(1):51-3. 2013
  • Okabayashi K, Hasegawa H, Watanabe M, Ohishi T, Hisa A, Kitagawa Y. Usefulness of the preoperative administration of tegafur suppositories as alternative adjuvant chemotherapy for patients with resectable stage II or III colorectal cancer: a KODK4 multicenter randomized control trial. Oncology. 2012;83(1):16-23.
  • Okabayashi K, Fujita T, Miyazaki J, Okada T, Iwata T, Hirao N, Noji S, Tsukamoto N, Goshima N, Hasegawa H, Takeuchi H, Ueda M, Kitagawa Y, Kawakami Y. Cancer-testis antigen BORIS is a novel prognostic marker for patients with esophageal cancer. Cancer Sci. Sep;103(9):1617-24. 2012
  • Okabayashi K, Ashrafian H, Hasegawa H, Yoo JH, Patel VM, Harling L, Rowland SP, Ali M, Kitagawa Y, Darzi A, Athanasiou T. Body mass index category as a risk factor for colorectal adenomas: a systematic review and meta-analysis. Am J Gastroenterol. Aug;107(8):1175-85. 2012
  • Garas G, Ibrahim A, Ashrafian H, Ahmed K, Patel V, Okabayashi K, Skapinakis P, Darzi A, Athanasiou T. Evidence-based surgery: barriers, solutions, and the role of evidence synthesis. World J Surg. Aug;36(8):1723-31. 2012
  • Kayani B, Okabayashi K, Ashrafian H, Harling L, Rao C, Darzi A, Kitagawa Y, Athanasiou T, Zacharakis E. Does obesity affect outcomes in patients undergoing esophagectomy for cancer? A meta-analysis. World J Surg. Aug;36(8):1785-95. 2012
  • Iida S, Hasegawa H, Okabayashi K, Moritani K, Mukai M, Kitagawa Y. Risk factors for postoperative recurrence in patients with pathologically T1 colorectal cancer. World J Surg. Feb;36(2):424-30. 2012
  • Ochiai H, Ohishi T, Osumi K, Tokuyama J, Urakami H, Seki S, Shimada A, Matsui A, Isobe Y, Murata Y, Endo T, Ishii Y, Hasegawa H, Matsumoto S, Kitagawa Y. Reevaluation of serum p53 antibody as a tumor marker in colorectal cancer patients. Surg Today. Jan;42(2):164-8. 2012
  • Hoshino Y, Hasegawa H, Ishii Y, Endo T, Ochiai H, Okabayashi K, Kaneko G, Mikami S, Mukai M, Oya M, Kitagawa Y. Two cases of bowel perforation associated with sunitinib treatment for renal cell carcinoma. Int J Clin Oncol. Aug;17(4):412-6. 2012

Copyright© 慶應義塾大学医学部外科(一般・消化器外科)腸班.
All rights reserved.